Antimicrobial and anti-inflammatory thermo-reversible hydrogel for periodontal delivery
10.1016/j.actbio.2020.09.018 · doi-reference
Proresolving nanomedicines activate bone regeneration in periodontitis
10.1177/0022034514557331 · doi-reference
Hierarchical chitin nanocrystal-based 3D printed dual-layer membranes hydrogels: A dual drug delivery nano-platform for periodontal tissue regeneration
10.1021/acsnano.4c05558 · doi-reference
Treatment of periodontal disease: Does drug delivery matter
10.3389/fbioe.2024.1427758 · doi-reference
Omega-3 PUFA and aspirin as adjuncts to periodontal debridement in patients with periodontitis and type 2 diabetes mellitus: Randomized clinical trial
10.1002/jper.19-0613 · doi-reference
Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue
10.1152/ajpcell.00024.2014 · doi-reference
E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinical trials, and targeted precision nutrition
10.1016/j.smim.2022.101597 · doi-reference
Optimizing delivery of specialized pro-resolving mediators for oral inflammation via smart hydrogels and biomaterials
10.1080/20415990.2025.2570109 · doi-reference
Maresin biosynthesis and identification of maresin 2, a new anti-inflammatory and pro-resolving mediator from human macrophages
10.1371/journal.pone.0102362 · doi-reference
Biosynthesis of the Maresin Intermediate, 13S,14S-Epoxy-DHA, by human 15-lipoxygenase and 12-lipoxygenase and its regulation through negative allosteric modulators
10.1021/acs.biochem.0c00233 · doi-reference
Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo
10.1073/pnas.96.14.8247 · doi-reference
Design of lipoxin A4 stable analogs that block transmigration and adhesion of human neutrophils
10.1021/bi00044a041 · doi-reference
Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: Evidence for anti-inflammatory receptors
10.1084/jem.185.9.1693 · doi-reference
Resolving lipoxin A4: Endogenous mediator or exogenous anti-inflammatory agent
10.1016/j.jlr.2024.100734 · doi-reference
Functional humanization of 15-lipoxygenase-1 (Alox15) protects mice from dextran sodium sulfate induced intestinal inflammation
10.1186/s11658-025-00756-0 · doi-reference
A signaling network map of lipoxin (LXA4): an anti-inflammatory molecule
10.1007/s00011-024-01885-6 · doi-reference
Promising anti-inflammatory tools: Biomedical efficacy of lipoxins and their synthetic pathways
10.3390/ijms241713282 · doi-reference
Lipoxin A4 yields an electrophilic 15-oxo metabolite that mediates FPR2 receptor-independent anti-inflammatory signaling
10.1016/j.jlr.2024.100705 · doi-reference
Impact of resolvin-E1 and maresin-1 on bone marrow stem cell osteogenesis under inflammatory stress
10.3390/cells13110932 · doi-reference
Stereoselective synthesis and structural confirmation of the specialized pro-resolving mediator resolvin E4
10.1021/acs.joc.0c02913 · doi-reference
The potential role of n-3 fatty acids and their lipid mediators on asthmatic airway inflammation
10.3389/fimmu.2024.1488570 · doi-reference
Resolving inflammation in CKD: The potential of SPMs and omega-3 derivatives as biomarkers and therapeutics
10.3390/biomedicines14030619 · doi-reference
The role of foreign body response in peri-implantitis: What is the evidence
10.1111/prd.12456 · doi-reference
The mechanism of efferocytosis in the pathogenesis of periodontitis and its possible therapeutic strategies
10.1093/jleuko/qiad016 · doi-reference
Low-dose pro-resolving mediators temporally reset the resolution response to microbial inflammation
10.1186/s10020-024-00877-w · doi-reference
Mechanistic and therapeutic insights into Nrf2-mediated redox regulation in periodontitis
10.3390/antiox15010072 · doi-reference
Maresin 1 biosynthesis and proresolving anti-infective functions with human-localized aggressive periodontitis leukocytes
10.1128/iai.01131-15 · doi-reference
Maresin1: A multifunctional regulator in inflammatory bone diseases
10.1016/j.intimp.2023.110308 · doi-reference
Maresin-1 and inflammatory disease
10.3390/ijms23031367 · doi-reference
MicroRNA 21 is a homeostatic regulator of macrophage polarization and prevents prostaglandin E2-mediated M2 generation
10.1371/journal.pone.0115855 · doi-reference
Maresin1 promotes M2 macrophage polarization through peroxisome proliferator-activated receptor-γ activation to expedite resolution of acute lung injury
10.1016/j.jss.2020.06.062 · doi-reference
Maresin 1 promotes wound healing and socket bone regeneration for alveolar ridge preservation
10.1177/0022034520917903 · doi-reference
Maresin 1 alleviates diabetic kidney disease via LGR6-mediated cAMP-SOD2-ROS pathway
10.1155/2022/7177889 · doi-reference
Protectin DX resolves fracture-induced postoperative pain in mice via neuronal signaling and GPR37-activated macrophage efferocytosis
10.1172/jci190754 · doi-reference
Protectin D1/GPR37 signaling enhances macrophage-dependent efferocytosis to attenuate experimental abdominal aortic aneurysm formation
10.1096/fj.202600063r · doi-reference
PDX regulates inflammatory cell infiltration via resident macrophage in LPS-induced lung injury
10.1111/jcmm.15679 · doi-reference
Recent advances in the chemistry and biology of anti-inflammatory and specialized pro-resolving mediators biosynthesized from n-3 docosapentaenoic acid
10.1016/j.bmcl.2017.03.079 · doi-reference
In vitro biosynthetic pathway investigations of neuroprotectin D1 (NPD1) and protectin DX (PDX) by human 12-lipoxygenase, 15-lipoxygenase-1, and 15-lipoxygenase-2
10.1021/acs.biochem.0c00931 · doi-reference
Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes
10.4049/jimmunol.176.3.1848 · doi-reference
Protectins: Their biosynthesis, metabolism and structure-functions
10.1016/j.bcp.2022.115330 · doi-reference
